Steven Cohen’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
LCM
KCM
SL
Steven Cohen's CGEM Position: Q3 2026 in Review
Steven Cohen sold out of Cullinan Therapeutics (CGEM) in Q3 2026, closing a stake of 75,009 shares — an estimated $1.37M sold.
Steven Cohen first reported a position in CGEM in Q2 2023 and held it in 5 quarters. The position peaked at $12.9M in Q1 2026. 182 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.
- Steven Cohen reported no remaining Cullinan Therapeutics position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 75,009 Cullinan Therapeutics shares in Q3 2026, an estimated $1.37M.
- Steven Cohen first reported a position in Cullinan Therapeutics in Q2 2023 and held it in 5 quarters.
- Steven Cohen's Cullinan Therapeutics position peaked at $12.9M in Q1 2026.
- 182 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.